Positions

Position Company Period
Independent Director Biogen Inc Jan. 3, 2010 -
Independent Director Intellia Therapeutics Inc Dec. 1, 2015 -
Independent Director Illumina Inc Jan. 26, 2017 -
Independent Trustee Goldman Sachs MLP and Energy Renaissance Fund Jan. 1, 2016 -
Independent Trustee Goldman Sachs MLP Income Opportunities Fund Sept. 15, 2016 -
Chief Financial Officer, Executive Vice President Public Service Enterprise Group Inc April 9, 2009 - Oct. 8, 2015
Caroline Dorsa's trades of Merck & Co Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-06-14 2021-06-10 PS Planned sale
1,000 -10.5%
450.00
USD 450,000
1,000 -10.5% 450.00 USD 450,000
2021-04-06 2021-04-05 PS Planned sale
800 -12.9%
82.99
USD 66,392
800 -12.9% 82.99 USD 66,392
2021-04-06 2021-04-05 PS Planned sale
4,686 -43.0%
82.35
USD 385,892
4,686 -43.0% 82.35 USD 385,892
2021-04-06 2021-04-05 PS Planned sale
2,014 -15.6%
81.49
USD 164,121
2,014 -15.6% 81.49 USD 164,121
2006-02-08 2006-02-07 S Sale
63,299 -80.2%
34.05
USD 2,155,356
63,299 -80.2% 34.05 USD 2,155,356
2004-10-27 2004-10-26 S Sale
25,000 -61.5%
30.35
USD 758,750
25,000 -61.5% 30.35 USD 758,750
2004-10-27 2004-10-26 S Sale
25,000 -38.1%
30.38
USD 759,500
25,000 -38.1% 30.38 USD 759,500
2004-10-27 2004-10-26 S Sale
13,299 -16.8%
30.39
USD 404,157
13,299 -16.8% 30.39 USD 404,157
// ... existing code ... // ... rest of the file ...